Síndrome de Steele Richardson-Olszewski: Revisión de tema

Resumen

Los síndromes de Parkinson atípicos como la parálisis supranuclear progresiva (PSP), también conocida como síndrome de Steele-Richardson-Olszewski son síndromes neurológicos atípicos de presentación tardía, con 7 variantes clínicas con supervivencia muy baja tras el diagnóstico, requiere de 1 manejo multidisciplinario para lograr los mejores objetivos, así como la participación activa del entorno familiar.

Palabras clave: parálisis, espranuclear, progresiva, síndrome, Steele-Richardson-Olszewski, síndrome de Parkinson acinético-rígido

Descargas

La descarga de datos todavía no está disponible.

Citas

Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM, (1995) Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. Journal of Neurology, Neurosurgery, and Psychiatry 58 (2), 167-73 https://pubmed.ncbi.nlm.nih.gov/7876846/

Gold M et al. (2012) Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy. Neuropsychiatric Disease and Treatment 8: 85-93 https://pubmed.ncbi.nlm.nih.gov/22347799/

Morris HR, Wood NW, Lees AJ (1999) Classic diseases revisited: Progressive supranuclear palsy (Steele-Richardson-Olszewski disease). Postgrad Med J 75 (888), 579–584. https://pmj.bmj.com/content/postgradmedj/75/888/579.full.pdf

Maher ER, Smith EM, Lees AJ (1985) Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Journal of Neurology, Neurosurgery, and Psychiatry 48 (12), 1234-1239. https://pubmed.ncbi.nlm.nih.gov/4086998/

Barclay CL & Lang AE (1997) Dystonia in progressive supranuclear palsy. Journal of Neurology, Neurosurgery, and Psychiatry 62 (4), 352–6. https://jnnp.bmj.com/content/62/4/352.long

Neophytides A et al. (1982) The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy. Journal of Neurology, Neurosurgery, and Psychiatry 45 (3), 261-3 https://pubmed.ncbi.nlm.nih.gov/7086448/

Tawana K & Ramsden DB (2001) Progressive supranuclear palsy. J Clin Pathol: Mol Pathol 54 (6), 427-34 https://pubmed.ncbi.nlm.nih.gov/11724919/

Williams DR & Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. The Lancet Neurology. 8 (3), 270–9. http://linkinghub.elsevier.com/ retrieve/pii/S1474442209700420.

Golbe LI (2018) A Clinician’s guide to Progressive Supranuclear Palsy 1th ed. New Jersey, USA: Rutgers University Press

Ali F & Josephs K. (2018) The diagnosis of progressive supranuclear palsy: current opinions and challenges. Expert Review of Neurotherapeutics 18 (7), 603-616 https://pubmed.ncbi.nlm.nih.gov/29902389/

Litvan I et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele- Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47 (1), 1-9 https://pubmed.ncbi.nlm.nih.gov/8710059/

Armstrong MJ (2018) Progressive Supranuclear Palsy: an Update. Current Neurology and Neuroscience Reports 18 (3), 12 https://pubmed.ncbi.nlm.nih.gov/29455271/

Höglinger GU et al. (2017) Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Movement Disorders 32 (6), 853–864 https://pubmed.ncbi.nlm.nih.gov/28467028/

Respondek G et al. (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Movement Disorders 29 (14), 1758-66 https://pubmed.ncbi.nlm.nih.gov/25370486/

McFarland NR (2016) Diagnostic Approach to Atypical Parkinsonian Syndromes. Continuum (Minneap Minn) 22 (4 Movement Disorders), 1117–1142 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567217/

Intiso D, Bartolo M, Santamato A, Di Rienzo F (2018) The Role of Rehabilitation in Patients With Progressive Supranuclear Palsy: A Narrative Review. PM & R 10 (6), 636-645. https://onlinelibrary.wiley.com/doi/abs/10.1016/j.pmrj.2017.12.011

Boxer AL et al (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. The Lancet Neurology 16 (7), 552-563 https://pubmed.ncbi.nlm.nih.gov/28653647/

Agarwal S & Gilbert R (2022) Progressive Supranuclear Palsy, Treasure Island (FL): StatPearls Publishing https://pubmed.ncbi.nlm.nih.gov/30252354/

Martín AL (2017) Plan de cuidados en paciente con parálisis supranuclear progresiva en fase avanzada, Revista Reduca 9 (1) http://revistareduca.es/index.php/reduca-enfermeria/article/view/1931

Ling H (2016) Clinical Approach to Progressive Supranuclear Palsy. Journal of Movement Disorders 9 (1), 3–13 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734991/

Publicado
2022-06-02
Cómo citar
Theran León, J. S., Dulcey Sarmiento, L. A., Forero Trillos , M. F., García Brilla , M. F., Gutiérrez Gómez , E. A., Ordoñez Llanes, K., & Sánchez Herrera, A. M. (2022). Síndrome de Steele Richardson-Olszewski: Revisión de tema. Ciencia Latina Revista Científica Multidisciplinar, 6(3), 1207-1215. https://doi.org/10.37811/cl_rcm.v6i3.2285
Sección
Artículos

Artículos más leídos del mismo autor/a